Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma.

MLA

El Sharouni, Mary-Ann, et al. “Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma.” JAMA Dermatology, vol. 157, no. 2, Feb. 2021, pp. 166–73. EBSCOhost, https://doi.org/10.1001/jamadermatol.2020.5032.

APA

El Sharouni, M.-A., Aivazian, K., Witkamp, A. J., Sigurdsson, V., van Gils, C. H., Scolyer, R. A., Thompson, J. F., van Diest, P. J., & Lo, S. N. (2021). Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma. JAMA Dermatology, 157(2), 166–173. https://doi.org/10.1001/jamadermatol.2020.5032

Chicago

El Sharouni, Mary-Ann, Karina Aivazian, Arjen J Witkamp, Vigfús Sigurdsson, Carla H van Gils, Richard A Scolyer, John F Thompson, Paul J van Diest, and Serigne N Lo. 2021. “Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma.” JAMA Dermatology 157 (2): 166–73. doi:10.1001/jamadermatol.2020.5032.